81 related articles for article (PubMed ID: 15894113)
1. Identification of NH(2)-terminal amino acid residues essential for the biological activity of leukotactin-1.
Lee JK; Kim HS; Im SA; Kim K; Kwon BS; Lee CK
Immunol Lett; 2005 Jun; 99(1):63-8. PubMed ID: 15894113
[TBL] [Abstract][Full Text] [Related]
2. Truncation of NH2-terminal amino acid residues increases agonistic potency of leukotactin-1 on CC chemokine receptors 1 and 3.
Lee JK; Lee EH; Yun YP; Kim K; Kwack K; Na DS; Kwon BS; Lee CK
J Biol Chem; 2002 Apr; 277(17):14757-63. PubMed ID: 11832479
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3.
Youn BS; Zhang SM; Lee EK; Park DH; Broxmeyer HE; Murphy PM; Locati M; Pease JE; Kim KK; Antol K; Kwon BS
J Immunol; 1997 Dec; 159(11):5201-5. PubMed ID: 9548457
[TBL] [Abstract][Full Text] [Related]
4. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
5. Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta).
Ott TR; Lio FM; Olshefski D; Liu XJ; Struthers RS; Ling N
Biochemistry; 2004 Mar; 43(12):3670-8. PubMed ID: 15035637
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
7. Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activity.
Macphee CH; Appelbaum ER; Johanson K; Moores KE; Imburgia CS; Fornwald J; Berkhout T; Brawner M; Groot PH; O'Donnell K; O'Shannessy D; Scott G; White JR
J Immunol; 1998 Dec; 161(11):6273-9. PubMed ID: 9834116
[TBL] [Abstract][Full Text] [Related]
8. Construction, purification and biological activities of recombinant human interleukin-2 analogs.
Boone T; Chazin V; Kenney W; Swanson E; Altrock B
Dev Biol Stand; 1988; 69():157-68. PubMed ID: 3066670
[TBL] [Abstract][Full Text] [Related]
9. Functional redundancy of the human CCL4 and CCL4L1 chemokine genes.
Howard OM; Turpin JA; Goldman R; Modi WS
Biochem Biophys Res Commun; 2004 Jul; 320(3):927-31. PubMed ID: 15240137
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the human CC chemokine 2: A monomeric representative of the CC chemokine subtype.
Sticht H; Escher SE; Schweimer K; Forssmann WG; Rösch P; Adermann K
Biochemistry; 1999 May; 38(19):5995-6002. PubMed ID: 10320325
[TBL] [Abstract][Full Text] [Related]
11. Leukotactin-1/CCL15-induced chemotaxis signaling through CCR1 in HOS cells.
Ko J; Kim IS; Jang SW; Lee YH; Shin SY; Min DS; Na DS
FEBS Lett; 2002 Mar; 515(1-3):159-64. PubMed ID: 11943214
[TBL] [Abstract][Full Text] [Related]
12. Analysis of eosinophils and myeloid progenitor responses to modified forms of MPIF-2.
Grzegorzewski KJ; Yao XT; Kreider B; Olsen HS; Morris TS; Zhang L; Sanyal I; Nardelli B; Zukauskas D; Brewer L; Bong GW; Kim Y; Garotta G; Salcedo TW
Cytokine; 2001 Feb; 13(4):209-19. PubMed ID: 11237428
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human LZIP expression by NF-kappaB and its involvement in monocyte cell migration induced by Lkn-1.
Jang SW; Kim YS; Kim YR; Sung HJ; Ko J
J Biol Chem; 2007 Apr; 282(15):11092-100. PubMed ID: 17296613
[TBL] [Abstract][Full Text] [Related]
14. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
15. Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function.
Zhong M; Parish B; Murtazina DA; Ku CY; Sanborn BM
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E977-84. PubMed ID: 17148753
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
17. Differential CCR1-mediated chemotaxis signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells.
Kim IS; Jang SW; Sung HJ; Lee JS; Ko J
FEBS Lett; 2005 Nov; 579(27):6044-8. PubMed ID: 16226254
[TBL] [Abstract][Full Text] [Related]
18. C-terminal amino acid residue loss for deprotonated peptide ions containing glutamic acid, aspartic acid, or serine residues at the C-terminus.
Li Z; Yalcin T; Cassady CJ
J Mass Spectrom; 2006 Jul; 41(7):939-49. PubMed ID: 16810639
[TBL] [Abstract][Full Text] [Related]
19. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation.
Lee JS; Kim IS
Mol Biol Rep; 2010 Jun; 37(5):2149-56. PubMed ID: 19669929
[TBL] [Abstract][Full Text] [Related]
20. The last five amino acid residues at the C-terminus of PRK1/PKN is essential for full lipid responsiveness.
Lim WG; Zhu Y; Wang CH; Tan BJ; Armstrong JS; Dokland T; Yang H; Zhu YZ; Teo TS; Duan W
Cell Signal; 2005 Sep; 17(9):1084-97. PubMed ID: 15993750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
